Exicure (NASDAQ: XCUR)
$8.77
(-2.4%)
-$0.22
Price as of June 13, 2025, 2:59 p.m. ET
Exicure Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Exicure Company Info
Exicure, Inc. develops therapeutics for immuno-oncology, genetic disorders and other indications based on its proprietary Spherical Nucleic Acid. Its product pipeline include Cavrotolimod (AST-008) and XCUR-FXN. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in June 2011 and is headquartered in Skokie, IL.
News & Analysis
No articles found.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.